| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.042 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.029 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |